Myriad Genetics Ltd

EndoPredict® is a multi-gene test for breast cancer patients

Video   •   Oct 24, 2014 09:52 BST

 
EndoPredict® is a multi-gene test for breast cancer patients. Using a specially developed procedure, it determines whether a given patient needs chemotherapy, or whether solely anti-hormonal therapy constitutes sufficient treatment. The method is based on analysis of tumour genes in combination with the classical prognostic factors of nodal status and tumour size.
License Creative Commons Attribution (?)
Video length 7:03